Email
IAC Express #1,544 - Your weekly immunization news service: Anaphylaxis, COVID-19 vaccine dosing intervals, and more
| From | Immunization Action Coalition <[email protected]> |
| Subject | IAC Express #1,544 - Your weekly immunization news service: Anaphylaxis, COVID-19 vaccine dosing intervals, and more |
| Date | January 13, 2021 11:48 AM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
Email not displaying correctly? View it in your browser. ([link removed] )
[link removed]
Issue 1,544: January 13, 2021
Top Stories
* “Allergic Reactions including Anaphylaxis after Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine—United States, December 14–23, 2020” published in MMWR
* Don't get it wrong! Schedule COVID-19 vaccine dose #2 at 21 or 28 days, not sooner, say CDC and FDA
* IAC launches "Vaccines: COVID-19" web page, directing you to the most important resources from CDC and others
* Reminder! Ask the Experts: COVID-19 web page answers your questions about COVID-19 vaccines
* HHS announces $22 billion in funding to support expanded COVID-19 testing and vaccination
* HHS releases national strategic plan to address viral hepatitis in the U.S.
* Voices for Vaccines releases new podcast, interviewing Stanley Plotkin on common COVID-19 vaccine questions
* “Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020” published in MMWR
* IAC experts called on by news media
* Not-to-miss immunization articles in the news
Vaccine Information Statements
* IAC posts revised French translation of the MMRV Vaccine Information Statement (VIS)
IAC Handouts
* New! IAC publishes “COVID-19 mRNA Vaccines: What Clinic Personnel Need to Know,” a side-by-side comparison of Pfizer-BioNTech and Moderna COVID-19 vaccines
* IAC updates "Decision to Not Vaccinate My Child – Declination Form"
Featured Resources
* CHOP’s Vaccine Education Center releases English- and Spanish-language versions of their COVID-19 mRNA Q&As
* In IAC’s “Video of the Week,” CDC's Dr. Amanda Cohn explains how ACIP advises CDC on use of vaccines
* Use IAC’s expanded “Repository of Resources for Maintaining Immunization during the COVID-19 Pandemic” to catch up people who fell behind
* Newly updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
* Great for workplace recognitions! IAC’s elegantly designed “Vaccines Save Lives” black enamel pins show how much you value vaccination.
* Check out IAC’s new website Mass-Vaccination-Resources.org to find resources to help set up your mass vaccination clinics—new resources added!
Journal Articles and Newsletters
* “A Quality Improvement Learning Collaborative for Human Papillomavirus Vaccination” published in Pediatric Quality and Safety
* “Population Mortality and Laws Encouraging Vaccination for Hospital Workers” published in Annals of Internal Medicine
Education and Training
* Moderna scientists will offer two webinars regarding mRNA COVID-19 vaccination on January 14 and 19
On the Lighter Side
* In this cute 1998 PSA from Nevada Health Division, a baby’s toys inform her that she can get the chickenpox vaccine
------------------------------------------------------------
Top Stories
------------------------------------------------------------
“ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS AFTER RECEIPT OF THE FIRST DOSE OF PFIZER-BIONTECH COVID-19 VACCINE—UNITED STATES, DECEMBER 14–23, 2020” published in MMWR
CDC published Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine—United States, December 14–23, 2020 ([link removed]) in an Early Release MMWR on January 6 ([link removed]) . Key findings in the report appear below.
* Early safety monitoring detected 21 cases of anaphylaxis after administration of 1,893,360 first doses of Pfizer-BioNTech COVID-19 vaccine (11.1 cases per million vaccine doses)
* 86% of anaphylaxis cases had symptom onset within 30 minutes of vaccination
* 81% of these cases had a history of allergies or allergic reactions, including some with previous anaphylaxis events
* 90% of these anaphylaxis cases after receipt of Pfizer-BioNTech COVID-19 vaccine occurred in women (a higher frequency than the 64% of recipients who are women)
* Anaphylaxis is potentially life-threatening and requires preparedness to start immediate treatment if it happens
* Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine appears to be a rare event
* CDC and FDA continue enhanced monitoring for anaphylaxis among recipients of COVID-19 vaccines
Based on these findings, CDC updated the allergy screening portion of the COVID-19 vaccination clinical considerations ([link removed]) to state that contraindications to vaccination with either the Pfizer-BioNTech or Moderna COVID-19 vaccines include a history of severe allergic reaction after a previous dose of an mRNA COVID-19 vaccine or any of its components or immediate allergic reaction of any severity to a previous dose of an mRNA COVID-19 vaccine or any of its components (including polyethylene glycol [PEG]) or polysorbate). Additional details appear in CDC clinical considerations ([link removed]) and in guidance on managing anaphylaxis ([link removed]) .
Access the MMWR article in HTML format ([link removed]) or in PDF format ([link removed]) .
Related Links
* CDC’s Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States ([link removed])
* CDC’s Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination ([link removed])
* MMWR ([link removed]) gateway page provides access to MMWR Weekly, MMWR Recommendations and Reports, MMWR Surveillance Summaries, and MMWR Supplements
------------------------------------------------------------
Don't get it wrong! Schedule COVID-19 vaccine dose #2 at 21 or 28 days, not sooner, say CDC and FDA
CDC and FDA each issued statements affirming the use of the standard dosing interval for the two authorized mRNA vaccines.
On January 6, CDC revised Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States ([link removed]) . The portion regarding dosing intervals is summarized below:
* Routine Scheduling. Do not schedule people to receive dose #2 earlier than recommended (i.e., 21 days for Pfizer-BioNTech or 28 days for Moderna).
* Inadvertent Early Doses. Dose #2 inadvertently administered as much as 4 days too early (“grace period”) should be considered valid.
* No Maximum Interval. There is no maximum interval between dose #1 and dose #2 for either vaccine. If dose #2 is administered beyond 21 or 28 days, there is no need to restart the series or repeat the dose.
* Errors. Vaccine administration errors should be reported to the Vaccine Adverse Event Reporting System (VAERS) ([link removed]) .
Visit CDC's COVID-19 Vaccination: Clinical Considerations ([link removed]) gateway page for more information.
On January 4, the U.S. Food and Drug Administration (FDA) issued FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines ([link removed]) . A portion of the statement is reprinted below.
Using a single dose regimen and/or administering less than the dose studied in the clinical trials without understanding the nature of the depth and duration of protection that it provides is concerning, as there is some indication that the depth of the immune response is associated with the duration of protection provided. If people do not truly know how protective a vaccine is, there is the potential for harm because they may assume that they are fully protected when they are not, and accordingly, alter their behavior to take unnecessary risks.
Related Links
* CDC's Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States ([link removed]) web page
* CDC's Pfizer-BioNTech COVID-19 Vaccine – Vaccine Preparation and Administration Summary ([link removed])
* CDC's Moderna COVID-19 Vaccine Preparation and Administration Summary ([link removed])
* CDC's Vaccines and Immunizations: mRNA COVID-19 Vaccines ([link removed]) gateway page
* CDC's Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination ([link removed]) web page
* FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines ([link removed])
* FDA’s COVID-19 Vaccines ([link removed]) gateway page
* IAC’s Ask the Experts: COVID-19 ([link removed]) web page
------------------------------------------------------------
IAC launches "Vaccines: COVID-19" web page, directing you to the most important resources from CDC and others
The large body of COVID-19 vaccine information continues to expand daily. To help healthcare professionals stay up to date with current versions of COVID-19 resources for frontline vaccinators, IAC has launched its new Vaccines: COVID-19 ([link removed]) web page at www.immunize.org/covid-19.
[link removed]
On this new web page, IAC has assembled links to key COVID-19 vaccine resource pages from CDC, IAC, and other medical and public health partners. To ease access, the web page is divided into topic areas, including:
* ACIP Recommendations
* CDC COVID-19 Vaccination Information (main page)
* Information about COVID-19 Vaccine Products
* Vaccine Fact Sheets for Recipients and Caregivers (EUA Vaccines)
* Clinic Resources and Tools (including vaccine administration, clinical considerations and special populations, safety, storage and handling, staff training materials, and reimbursement)
* Patient Education Tools
* Vaccine Confidence and Hesitancy
* Frequently Asked Questions
* Key Contacts for COVID-19 Vaccine Information and Policies
There are three ways to easily locate the new web page:
* From the yellow box at the top of the IAC home page ([link removed])
* Use www.immunize.org/covid-19
* Go to the light blue band of tabs across the top of any IAC web page, choose the "Vaccines” tab, and then select “COVID-19”
The Vaccines: COVID-19 ([link removed]) web page will be updated frequently, so check back regularly for the most current information.
Related Links
* IAC’s Ask the Experts: COVID-19 ([link removed]) web page
* IAC’s Ask the Experts: COVID-19 and Routine Vaccination ([link removed]) web page
* IAC's Clinic Tools: Vaccination and COVID-19 ([link removed]) web page
------------------------------------------------------------
Reminder! Ask the Experts: COVID-19 web page answers your questions about COVID-19 vaccines
IAC recently created its Ask the Experts: COVID-19 ([link removed]) web page to answer questions about the administration of mRNA COVID-19 vaccines authorized for emergency use by the FDA and recommended by CDC’s Advisory Committee on Immunization Practices. This Ask the Experts web page also provides links to CDC guidance that will likely evolve. The Ask the Experts: COVID-19 ([link removed]) web page will grow as more information becomes available and whenever new vaccines are authorized.
IAC’s Ask the Experts ([link removed]) gateway page leads you to 29 distinct web pages on a variety of topics comprising a total of more than 1,000 common or challenging questions and answers (Q&As) about vaccines and their administration. IAC wishes to recognize its team of experts: Kelly L. Moore, MD, MPH (lead); Carolyn Bridges, MD, FACP; William Atkinson, MD, MPH; and Deborah Wexler, MD.
[link removed]
Related Links
* IAC’s Ask the Experts: COVID-19 ([link removed]) web page
* IAC’s Ask the Experts: COVID-19 and Routine Vaccination ([link removed]) web page
* IAC's Ask the Experts ([link removed]) gateway page to access more than 1,000 questions answered by IAC experts
------------------------------------------------------------
HHS announces $22 billion in funding to support expanded COVID-19 testing and vaccination
In a January 6 press release ([link removed]) , the Department of Health and Human Services (HHS) announced the Coronavirus Response and Relief Supplemental Appropriations Act will enable the CDC to provide more than $22 billion ([link removed]) [link removed] funding to states, localities, and territories to support the nation’s response to the COVID-19 pandemic.
The $22 billion includes $19 billion for testing and $3 billion for vaccination activities ([link removed]) . The funding is to be disbursed by January 19, 2021, to support testing and vaccination-related activities. Award recipients will include 64 jurisdictions including all 50 states, the District of Columbia, five major cities, and U.S. territories/islands. Funds will be allocated by a population-based formula.
For more information about CDC’s ongoing support to states, please visit this CDC's COVID-19 Budget Fact Sheet ([link removed]) gateway page.
Related Links
* HHS Press Release ([link removed]) (1/6/21)
* HHS's CDC Funding for COVID-19 Vaccination Activities ([link removed])
* HHS's CDC Funding for COVID-19 Testing ([link removed])
------------------------------------------------------------
HHS releases national strategic plan to address viral hepatitis in the U.S.
On January 7, the U.S. Department of Human Health Services (HHS) released its Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination 2021–2025 ([link removed]) to address this serious, preventable public health threat.
[link removed]
The Viral Hepatitis Plan for 2021–25 focuses on hepatitis A, hepatitis B, and hepatitis C, the three most common hepatitis viruses affecting the health of the nation. The plan identifies populations that experience the highest burden of viral hepatitis so that federal agencies and other stakeholders can focus their resources for the greatest effect.
The Viral Hepatitis Plan includes five goals to guide planning efforts:
* Prevent new viral hepatitis infections
* Improve health outcomes of people with viral hepatitis
* Reduce viral hepatitis-related disparities and health inequities
* Improve viral hepatitis surveillance and data use
* Achieve integrated, coordinated efforts that address the viral hepatitis epidemics among all partners and stakeholders
Related Links
* HHS's Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination 2021–2025 ([link removed])
* HHS's Viral Hepatitis National Strategic Plan Overview ([link removed]) webpage
* CDC's Viral Hepatitis ([link removed]) gateway page
------------------------------------------------------------
Voices for Vaccines releases new podcast, interviewing Stanley Plotkin on common COVID-19 vaccine questions
Voices for Vaccines (VFV) has posted a new entry in its Vax Talk podcast series: Let’s Ask Dr. Stanley Plotkin About These COVID-19 Vaccines ([link removed]) . A description from their web page is reprinted below.
Millions of people have received a COVID-19 vaccine, which gives us a lot of information about the safety of these vaccines. We asked Dr. Stanley Plotkin, inventor of the rubella vaccine and co-inventor of a rotavirus vaccine, to join us to answer our questions and to make some predictions.
[link removed]
Voices for Vaccines is a national organization of parents and others who are dedicated to raising the level of the voices of immunization supporters. VFV invites everyone who values vaccines to become a member, use VFV tools in their own community, and sign up for VFV’s free newsletter ([link removed]) . Please spread the word to your friends and colleagues to join VFV!
Related Links
* Voices for Vaccines ([link removed]) website
* Voices for Vaccines Tools ([link removed]) gateway page
* JoinVoices for Vaccines ([link removed]) and receive weekly email updates
* FollowVoices for Vaccines on Facebook ([link removed])
------------------------------------------------------------
“Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020” published in MMWR
CDC published Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020 ([link removed]) . A portion of the summary section is reprinted below.
ACIP recommends preexposure vaccination with Ervebo for adults aged ≥18 years in the U.S. population who are at highest risk for potential occupational exposure to Ebola virus species Zaire ebolavirus because they are responding to an outbreak of EVD, work as health care personnel at federally designated Ebola treatment centers in the United States, or work as laboratorians or other staff at biosafety level 4 facilities in the United States. Recommendations for use of Ervebo in additional populations at risk for exposure and other settings will be considered and discussed by ACIP in the future.
Access the MMWR article in HTML format ([link removed]) or in PDF format ([link removed]) .
Related Link
* MMWR ([link removed]) gateway page provides access to MMWR Weekly, MMWR Recommendations and Reports, MMWR Surveillance Summaries, and MMWR Supplements
------------------------------------------------------------
IAC experts called on by news media
With vaccines in the news so much lately, journalists have sought out IAC experts to communicate the intricacies of running a quality vaccination program. Our insights have helped explain vaccines to the public and policy makers. We want to help them understand the complex work vaccinators do. We've reached mass markets and local stations, across the U.S. and overseas, via print, radio, television, blogs, and more. Here is a selection of our recent citations:
* The Atlantic: The Next Phase of Vaccination Will Be Even Harder ([link removed] ) (1/7/21)
* Business Insider: Moderna's COVID-19 Vaccine May Cause Temporary Swelling for People with Facial Fillers ([link removed]) (12/30/20)
* Business Insider: In Rare Cases, COVID-19 Survivors Can Develop Psychosis and Suicidal Thoughts ([link removed]) (12/30/20)
* The Atlantic: Where Year Two of the Pandemic Will Take Us ([link removed]) (12/29/20)
* Minnesota Public Radio: Answering Questions about Vaccine Purgatory ([link removed]) (12/28/20)
* RadioLab: A Terrible COVID Christmas Special ([link removed]) (12/23/20)
------------------------------------------------------------
Not-to-miss immunization articles in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* CNN:[link removed] Will Release Nearly All Available Vaccine Doses in Break from Trump Administration Policy of Holding Back Stock for Second Dose ([link removed]) (1/8/21)
* STAT: Scientists Are Monitoring a Coronavirus Mutation That Could Affect the Strength of Vaccines ([link removed]) (1/7/21)
* Medscape: How to Report COVID Vaccine-Related Adverse Events ([link removed]) (1/6/21)
* Live Science: COVID-19 Vaccines May Cause Allergic Reactions in 1 in 100,000 Jabs ([link removed]) (1/6/21)
* The Guardian: Misinformation 'Superspreaders': COVID Vaccine Falsehoods Still Thriving on Facebook and Instagram ([link removed]) (1/6/21)
* USA Today: COVID-19 Vaccine Doses Have Been Delivered but Are Sitting on Pharmacy Shelves. Longer Delays Could Prolong the Pandemic ([link removed]) (1/5/21)
* New York Times: Echoes of Another Pandemic: How The Times Covered the 1918 Flu ([link removed]) (1/5/21)
* New York Times: How Nine COVID-19 Vaccines Work ([link removed]) (1/5/21)
* Medical Express: State Laws Promoting Flu Vaccination for Hospital Workers May Help Prevent Deaths from Flu and Pneumonia ([link removed]) (1/5/21)
* NBC News: The COVID Vaccine Is Safe, Whatever Anti-vaxxers Say. Here's Why We Can Trust It ([link removed]) (1/4/21)
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
IAC posts revised French translation of the MMRV Vaccine Information Statement (VIS)
IAC recently posted a revised French translation of the MMRV Vaccine (Measles, Mumps, Rubella, and Varicella) VIS ([link removed]) . The translation was generously contributed by Georgetown Translators.
[link removed]
Related Links
* English-language version of the ([link removed]) MMRV Vaccine (Measles, Mumps, Rubella, and Varicella) VIS ([link removed])
* French-language translation ([link removed]) MMRV Vaccine (Measles, Mumps, Rubella, and Varicella) VIS ([link removed])
* IAC's French-language versions of VISs ([link removed])
* IAC's MMRV Vaccine (Measles, Mumps, Rubella, and Varicella) VIS ([link removed]) gateway page
* IAC's VIS gateway page grouped by vaccine ([link removed])
* IAC’s VISs grouped in up to 49 languages ([link removed])
* CDC's What's New with VISs ([link removed]) gateway page
* CDC's VIS gateway page ([link removed])
------------------------------------------------------------
IAC Handouts
------------------------------------------------------------
NEW! IAC PUBLISHES “COVID-19 MRNA VACCINES: WHAT CLINIC PERSONNEL NEED TO KNOW,” A SIDE-BY-SIDE COMPARISON OF PFIZER-BIONTECH AND MODERNA COVID-19 VACCINES
IAC has released its newest resource for healthcare professionals, COVID-19 mRNA Vaccines: What Clinic Personnel Need to Know ([link removed]) , a 5-page summary offering a side-by-side comparison of the two FDA-authorized mRNA COVID-19 vaccines.
The table lists key characteristics of and resources for the Pfizer-BioNTech and Moderna mRNA vaccines. The resource presents information on each vaccine, including summary guidance and links to key resources available from CDC, FDA, and the vaccine manufacturers. Topics covered for each vaccine include:
* Age indication
* Presentation and packaging
* Storage and handling
* Vaccine preparation and administration
* Vaccine safety
* Vaccine product and administration codes
[link removed]
“COVID-19 mRNA Vaccines: What Clinic Personnel Need to Know” will be updated as new key resources become available.
Related Links
* IAC’s Handouts: COVID-19 ([link removed]) web page
* IAC’s Handouts for Patients and Staff ([link removed]) gateway page, where you can sort materials by topic, vaccine, or language
* IAC’s Educational Materials for Patients and Staff ([link removed]) —an alphabetical listing of more than 300 ready-to-print staff educational materials and patient handouts
* IAC's Vaccines: COVID-19 ([link removed]) web page
* IAC’s Ask the Experts: COVID-19 ([link removed]) web page
------------------------------------------------------------
IAC updates “Decision to Not Vaccinate My Child – Declination Form”
IAC recently revised its Decision to Not Vaccinate My Child – Declination Form ([link removed]) , adding “Declination Form” to the title and updating explanatory statements and references.
[link removed]
Related Links
* IAC's Handouts: Documenting Vaccination ([link removed]) gateway page
* IAC’s Handouts for Patients and Staff ([link removed]) gateway page, where you can sort materials by topic, vaccine, or language
* IAC’s Educational Materials for Patients and Staff ([link removed]) —an alphabetical listing of more than 300 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
CHOP’s Vaccine Education Center releases English- and Spanish-language versions of their COVID-19 mRNA Q&As
Children's Hospital of Philadelphia's (CHOP) Vaccine Education Center has released a 4-page, printable Q&A for the public titled COVID-19 mRNA Vaccines: What You Should Know ([link removed]) .
View the handout in Spanish ([link removed]) .
[link removed]
As with their other Q&A sheets, these sheets can be photocopied for distribution, and the links can be added to websites. Print versions will be available in coming weeks.
Related Links
* CHOP's Questions and Answers about COVID-19 Vaccines ([link removed]) web page
* The Vaccine Makers Project's The Coronavirus Pandemic––Answering Your Questions ([link removed]) web page
------------------------------------------------------------
IN IAC’S “VIDEO OF THE WEEK,” CDC'S DR. AMANDA COHN EXPLAINS HOW ACIP ADVISES CDC ON USE OF VACCINES
In this CDC video ([link removed]) , Dr. Amanda Cohn, executive secretary of CDC’s Advisory Committee on Immunization Practices (ACIP), explains that ACIP consists of independent experts who debate and develop recommendations on using vaccines to control vaccine-preventable diseases, including COVID-19. The committee prioritizes safety and effectiveness while reviewing scientific evidence.
[link removed]
Visit the whole collection at the VOTW archive ([link removed]) .
------------------------------------------------------------
USE IAC’S EXPANDED “REPOSITORY OF RESOURCES FOR MAINTAINING IMMUNIZATION DURING THE COVID-19 PANDEMIC” TO CATCH UP PEOPLE WHO FELL BEHIND
IAC now offers more than 275 items in its Repository of Resources for Maintaining Immunization during the COVID-19 Pandemic ([link removed]) gateway page to assist in maintaining routine immunization rates during the COVID-19 pandemic. Located on the website of the National Network of Immunization Coalitions ([link removed]) , a project of IAC, this repository includes links to both national and state-level policies and guidance; advocacy materials, including talking points, webinars, press releases, articles, and social media posts; and telehealth resources.
These resources are intended for healthcare settings, state and local health departments, professional societies, immunization coalitions, advocacy groups, and the community to use in their efforts to sustain routine immunizations during the COVID-19 pandemic. The resources can be sorted and searched by date, title, geographic area, source, type, age category, or setting.
[link removed]
If you have a resource to suggest for the repository, please send a message to [email protected] (mailto:[email protected]) .
Related Link
* National Network of Immunization Coalitions ([link removed]) website
------------------------------------------------------------
Newly updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
Confident recommendations for flu vaccine from healthcare providers are powerfully persuasive and make a significant difference in decisions your patients make about vaccination. To assist you in maximizing protection for your patients, IAC, in collaboration with Seqirus, has updated the 65+ Flu Defense website at www.influenza-defense.org ([link removed]) .
A new fact sheet on the site, ([link removed]) The Importance of Preventing Influenza during a Pandemic ([link removed]) , ([link removed]) [link removed] responses to help guide discussions with patients on the increased importance of flu vaccination during the COVID-19 pandemic. Age increases risks associated with COVID-19 infection including hospitalization and death. Preliminary studies suggest coinfection with influenza B and SARS-CoV-2 may elevate the risk of poor outcomes.
[link removed]
This helpful site includes information, tools, and tips for communicating with these adults about the scope and severity of influenza, for example:
* Influenza in Adults 65+: The Facts ([link removed])
* Influenza Vaccination: Questions Patients Age 65 and Older Frequently Ask Their HCP ([link removed])
Be sure to check out the updated 65+ Flu Defense website at www.influenza-defense.org ([link removed]) to assist your efforts in protecting this vulnerable population.
------------------------------------------------------------
=GREAT FOR WORKPLACE RECOGNITIONS! IAC’S ELEGANTLY DESIGNED “VACCINES SAVE LIVES” BLACK ENAMEL PINS SHOW HOW MUCH YOU VALUE VACCINATION.=
IAC’s elegantly designed “Vaccines Save Lives” pins ([link removed]) are meaningful gifts for people who care about immunization. The pin makes a refined statement in hard black enamel with gold lettering and edges, measuring 1.125" x 0.75".
[link removed]
The pin is a stick-through-post variety with the back end covered by a round rubber cap that holds the pin securely. A gold metal spring-lock clasp is also provided.
Wear these pins on clothing, ([link removed]) uniforms, and white coats to show that you value vaccines! They make a meaningful gift for people who care about immunization.
([link removed])
Click here for "Vaccines Save Lives" pin pricing and ordering information. ([link removed])
------------------------------------------------------------
CHECK OUT IAC’S NEW WEBSITE MASS-VACCINATION-RESOURCES.ORG TO FIND RESOURCES TO HELP SET UP YOUR MASS VACCINATION CLINICS—NEW RESOURCES ADDED!
The Immunization Action Coalition’s newest website, www.Mass-Vaccination-Resources.org ([link removed]), assists you in finding a wide range of ideas for developing your own mass vaccination clinics. Mass vaccination efforts will be useful for expediting flu vaccination this fall and may be needed after COVID-19 vaccines are licensed for use in large groups of people.
The website features a searchable list of resources for a variety of venues, including curbside, drive-through, and walk-through clinics; mobile medical vans; pharmacies; and schools. The database contains guidance documents, toolkits, publications, and other helpful resources that can be adapted to your community or individual healthcare setting.
Many of the documents were written in the pre-pandemic era and will need modification to ensure that additional protections, such as social distancing and personal protective equipment, help safeguard against COVID-19 transmission.
[link removed]
More resources have been added including:
* COVID-19 Vaccination Program Provider Requirements and Support ([link removed])
* COVID-19 Vaccination Resources for Providers ([link removed])
* Enrollment Process to Bill CMS for Vaccination Services ([link removed])
* COVID-19 Mass Vaccination Planning Guide ([link removed])
In addition, IAC's archived, full-length webinar highlighting best practices and offering practical information for conducting a successful mass vaccination clinic, Mass Vaccination Clinics: Challenges and Best Practices ([link removed]) , can also be viewed on www.Mass-Vaccination-Resources.org ([link removed]) .
If you have a resource to suggest for the website, please send a message to [email protected] (mailto:[email protected]) .
The webinar and the new website are supported by a medical education grant from Seqirus.
Related Links
* IAC's Mass Vaccination Resources ([link removed]) website
* CDC’s Guidance for Planning Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations ([link removed])
* IAC's Mass Vaccination Clinics: Challenges and Best Practices ([link removed]) archived webinar
* Becker’s Hospital Review: Influenza Vaccination Is More Important than Ever: To Help, Immunization Action Coalition Launches New Mass Vaccination Resources ([link removed])
------------------------------------------------------------
Journal Articles and Newsletters
------------------------------------------------------------
“A Quality Improvement Learning Collaborative for Human Papillomavirus Vaccination” published in Pediatric Quality and Safety
In the January/February 2021 issue, Pediatric Quality and Safety published A Quality Improvement Learning Collaborative for Human Papillomavirus Vaccination ([link removed]) . The senior author on the project is IAC’s Sharon G. Humiston, MD, MPH. The conclusion section is reprinted below.
This learning collaborative aimed to engage multiple AAP chapters and pediatric practices to teach QI skills and improve HPV vaccination rates using the Project ECHO telementoring platform. At the chapter level, the collaborative demonstrated success in satisfaction and in teaching the necessary skills to allow all participating chapters to go on to lead HPV QI learning collaboratives of their own. At the practice level, participants gained confidence in HPV vaccine communication and QI skills. The collaborative demonstrated early improvements in reducing missed opportunities to vaccinate, while the impact on HPV vaccination initiation and completion lagged. Future projects should be extended for more than 8 data cycles or use more frequent data collection to capture this change and further identify barriers to system-level change.
------------------------------------------------------------
“Population Mortality and Laws Encouraging Vaccination for Hospital Workers” published in Annals of Internal Medicine
In the January 5 issue, Annals of Internal Medicine published Population Mortality and Laws Encouraging Vaccination for Hospital Workers ([link removed]) . The conclusion section is reprinted below.
State laws promoting hospital worker vaccination against influenza may be effective in preventing pneumonia- and influenza-related deaths, particularly among elderly persons. Vaccinating hospital workers may substantially reduce the spread of influenza and protect the most vulnerable populations.
------------------------------------------------------------
Education and Training
------------------------------------------------------------
MODERNA SCIENTISTS WILL OFFER TWO WEBINARS REGARDING MRNA COVID-19 VACCINATION ON JANUARY 14 AND 19
Moderna will offer two webinars on mRNA vaccination against SARS-CoV-2, the virus that causes COVID-19. Ashfield Healthcare will coordinate the webinars on behalf of Moderna. CE credit will not be offered for these webinars.
On January 14, the webinar titled Important Information for Healthcare Providers about Moderna COVID-19 Vaccine ([link removed]) will start at 11:00 a.m. (ET).
Register for the January 14 webinar. ([link removed])
On January 19, the webinar Examining the SARS-CoV-2 Pandemic and the Moderna COVID-19 Vaccine: A Panel Discussion will be held from 7:00–8:00 p.m. (ET). This will be a conversational 1-hour presentation examining evolving epidemiology, the vaccine development timeline, the mRNA mechanism of action, and clinical data supporting an Emergency use Authorization (EUA).
Register for the January 19 webinar. ([link removed])
Related Links
* FDA's Moderna COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers ([link removed])
* FDA's Moderna COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers ([link removed])
------------------------------------------------------------
On the Lighter Side
------------------------------------------------------------
IN THIS CUTE 1998 PSA FROM NEVADA HEALTH DIVISION, A BABY’S TOYS INFORM HER THAT SHE CAN GET THE CHICKENPOX VACCINE
In this cute 1998 public service announcement (PSA) ([link removed]) from the Nevada Health Division, a baby’s toys explain the importance of getting the chickenpox vaccine to help protect her from the potentially deadly disease. This PSA is part of a collection curated by vaccine expert William L. Atkinson, MD, MPH.
[link removed]
Previous PSAs featured in “On the Lighter Side” are available when viewing this Vimeo video ([link removed]).
[link removed]
IAC Express
IAC Express Home ([link removed])
2020 Issues ([link removed])
2019 Issues ([link removed])
2018 Issues ([link removed])
2017 ([link removed]) – (#IACX4) 1997 Issues ([link removed])
[link removed]
[link removed]
------------------------------------------------------------
Video of the Week
[link removed]
How CDC Develops COVID-19 Vaccine Recommendations: Dr. Amanda Cohn, executive secretary of CDC’s Advisory Committee on Immunization Practices (ACIP), explains that ACIP consists of independent experts who debate and develop recommendations on using vaccines to control vaccine-preventable diseases, including COVID-19. The committee prioritizes safety and effectiveness while reviewing scientific evidence. [1:44]
Visit the VOTW archive ([link removed])
------------------------------------------------------------
[link removed]
[link removed]
------------------------------------------------------------
Follow Us
[link removed]
[link removed]
------------------------------------------------------------
Technically Speaking
[link removed]
Read Dr. Wexler's column for the Vaccine Education Center's monthly newsletter, Vaccine Update
------------------------------------------------------------
[link removed]
[link removed]
------------------------------------------------------------
Vaccinating Adults:
A Step-by-Step Guide
[link removed]
New! IAC's 142-page book available for free download ([link removed]) .
------------------------------------------------------------
Calendar of Events
[link removed]
Conferences, meetings, and training opportunities
------------------------------------------------------------
Patient Record Cards
[link removed]
Record cards for patients --child & teen ([link removed]) , adult ([link removed]) , and lifetime ([link removed]) -- are printed on durable paper and sized to fit in a wallet when folded
------------------------------------------------------------
DVD: Immunization Techniques
[link removed]
Every practice should have this award winning, "how-to" training video
------------------------------------------------------------
Protect Newborns Guidebook
[link removed]
Comprehensive guide Hepatitis B: What Hospitals Need to Do to Protect Newborns ([link removed])
------------------------------------------------------------
Editorial Information
Editor
Deborah L. Wexler, MD (mailto:[email protected])
Associate Editors
John Grabenstein, RPh, PhD (mailto:[email protected])
Sharon Humiston, MD, MPH (mailto:[email protected])
Consulting Editors
Taryn Chapman, MS (mailto:[email protected])
Marian Deegan, JD (mailto:[email protected])
Courtnay Londo, MA (mailto:[email protected])
Technical Editor
Liv Augusta Anderson, MPP (mailto:[email protected])
About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue. ([link removed] )
IAC Express is supported in part by Grant No. 6NH23IP922550 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC.
IAC Express Disclaimer ([link removed])
ISSN: 1526-1786
Our mailing address:
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
[link removed]
Issue 1,544: January 13, 2021
Top Stories
* “Allergic Reactions including Anaphylaxis after Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine—United States, December 14–23, 2020” published in MMWR
* Don't get it wrong! Schedule COVID-19 vaccine dose #2 at 21 or 28 days, not sooner, say CDC and FDA
* IAC launches "Vaccines: COVID-19" web page, directing you to the most important resources from CDC and others
* Reminder! Ask the Experts: COVID-19 web page answers your questions about COVID-19 vaccines
* HHS announces $22 billion in funding to support expanded COVID-19 testing and vaccination
* HHS releases national strategic plan to address viral hepatitis in the U.S.
* Voices for Vaccines releases new podcast, interviewing Stanley Plotkin on common COVID-19 vaccine questions
* “Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020” published in MMWR
* IAC experts called on by news media
* Not-to-miss immunization articles in the news
Vaccine Information Statements
* IAC posts revised French translation of the MMRV Vaccine Information Statement (VIS)
IAC Handouts
* New! IAC publishes “COVID-19 mRNA Vaccines: What Clinic Personnel Need to Know,” a side-by-side comparison of Pfizer-BioNTech and Moderna COVID-19 vaccines
* IAC updates "Decision to Not Vaccinate My Child – Declination Form"
Featured Resources
* CHOP’s Vaccine Education Center releases English- and Spanish-language versions of their COVID-19 mRNA Q&As
* In IAC’s “Video of the Week,” CDC's Dr. Amanda Cohn explains how ACIP advises CDC on use of vaccines
* Use IAC’s expanded “Repository of Resources for Maintaining Immunization during the COVID-19 Pandemic” to catch up people who fell behind
* Newly updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
* Great for workplace recognitions! IAC’s elegantly designed “Vaccines Save Lives” black enamel pins show how much you value vaccination.
* Check out IAC’s new website Mass-Vaccination-Resources.org to find resources to help set up your mass vaccination clinics—new resources added!
Journal Articles and Newsletters
* “A Quality Improvement Learning Collaborative for Human Papillomavirus Vaccination” published in Pediatric Quality and Safety
* “Population Mortality and Laws Encouraging Vaccination for Hospital Workers” published in Annals of Internal Medicine
Education and Training
* Moderna scientists will offer two webinars regarding mRNA COVID-19 vaccination on January 14 and 19
On the Lighter Side
* In this cute 1998 PSA from Nevada Health Division, a baby’s toys inform her that she can get the chickenpox vaccine
------------------------------------------------------------
Top Stories
------------------------------------------------------------
“ALLERGIC REACTIONS INCLUDING ANAPHYLAXIS AFTER RECEIPT OF THE FIRST DOSE OF PFIZER-BIONTECH COVID-19 VACCINE—UNITED STATES, DECEMBER 14–23, 2020” published in MMWR
CDC published Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine—United States, December 14–23, 2020 ([link removed]) in an Early Release MMWR on January 6 ([link removed]) . Key findings in the report appear below.
* Early safety monitoring detected 21 cases of anaphylaxis after administration of 1,893,360 first doses of Pfizer-BioNTech COVID-19 vaccine (11.1 cases per million vaccine doses)
* 86% of anaphylaxis cases had symptom onset within 30 minutes of vaccination
* 81% of these cases had a history of allergies or allergic reactions, including some with previous anaphylaxis events
* 90% of these anaphylaxis cases after receipt of Pfizer-BioNTech COVID-19 vaccine occurred in women (a higher frequency than the 64% of recipients who are women)
* Anaphylaxis is potentially life-threatening and requires preparedness to start immediate treatment if it happens
* Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine appears to be a rare event
* CDC and FDA continue enhanced monitoring for anaphylaxis among recipients of COVID-19 vaccines
Based on these findings, CDC updated the allergy screening portion of the COVID-19 vaccination clinical considerations ([link removed]) to state that contraindications to vaccination with either the Pfizer-BioNTech or Moderna COVID-19 vaccines include a history of severe allergic reaction after a previous dose of an mRNA COVID-19 vaccine or any of its components or immediate allergic reaction of any severity to a previous dose of an mRNA COVID-19 vaccine or any of its components (including polyethylene glycol [PEG]) or polysorbate). Additional details appear in CDC clinical considerations ([link removed]) and in guidance on managing anaphylaxis ([link removed]) .
Access the MMWR article in HTML format ([link removed]) or in PDF format ([link removed]) .
Related Links
* CDC’s Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States ([link removed])
* CDC’s Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination ([link removed])
* MMWR ([link removed]) gateway page provides access to MMWR Weekly, MMWR Recommendations and Reports, MMWR Surveillance Summaries, and MMWR Supplements
------------------------------------------------------------
Don't get it wrong! Schedule COVID-19 vaccine dose #2 at 21 or 28 days, not sooner, say CDC and FDA
CDC and FDA each issued statements affirming the use of the standard dosing interval for the two authorized mRNA vaccines.
On January 6, CDC revised Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States ([link removed]) . The portion regarding dosing intervals is summarized below:
* Routine Scheduling. Do not schedule people to receive dose #2 earlier than recommended (i.e., 21 days for Pfizer-BioNTech or 28 days for Moderna).
* Inadvertent Early Doses. Dose #2 inadvertently administered as much as 4 days too early (“grace period”) should be considered valid.
* No Maximum Interval. There is no maximum interval between dose #1 and dose #2 for either vaccine. If dose #2 is administered beyond 21 or 28 days, there is no need to restart the series or repeat the dose.
* Errors. Vaccine administration errors should be reported to the Vaccine Adverse Event Reporting System (VAERS) ([link removed]) .
Visit CDC's COVID-19 Vaccination: Clinical Considerations ([link removed]) gateway page for more information.
On January 4, the U.S. Food and Drug Administration (FDA) issued FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines ([link removed]) . A portion of the statement is reprinted below.
Using a single dose regimen and/or administering less than the dose studied in the clinical trials without understanding the nature of the depth and duration of protection that it provides is concerning, as there is some indication that the depth of the immune response is associated with the duration of protection provided. If people do not truly know how protective a vaccine is, there is the potential for harm because they may assume that they are fully protected when they are not, and accordingly, alter their behavior to take unnecessary risks.
Related Links
* CDC's Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States ([link removed]) web page
* CDC's Pfizer-BioNTech COVID-19 Vaccine – Vaccine Preparation and Administration Summary ([link removed])
* CDC's Moderna COVID-19 Vaccine Preparation and Administration Summary ([link removed])
* CDC's Vaccines and Immunizations: mRNA COVID-19 Vaccines ([link removed]) gateway page
* CDC's Interim Considerations: Preparing for the Potential Management of Anaphylaxis after COVID-19 Vaccination ([link removed]) web page
* FDA Statement on Following the Authorized Dosing Schedules for COVID-19 Vaccines ([link removed])
* FDA’s COVID-19 Vaccines ([link removed]) gateway page
* IAC’s Ask the Experts: COVID-19 ([link removed]) web page
------------------------------------------------------------
IAC launches "Vaccines: COVID-19" web page, directing you to the most important resources from CDC and others
The large body of COVID-19 vaccine information continues to expand daily. To help healthcare professionals stay up to date with current versions of COVID-19 resources for frontline vaccinators, IAC has launched its new Vaccines: COVID-19 ([link removed]) web page at www.immunize.org/covid-19.
[link removed]
On this new web page, IAC has assembled links to key COVID-19 vaccine resource pages from CDC, IAC, and other medical and public health partners. To ease access, the web page is divided into topic areas, including:
* ACIP Recommendations
* CDC COVID-19 Vaccination Information (main page)
* Information about COVID-19 Vaccine Products
* Vaccine Fact Sheets for Recipients and Caregivers (EUA Vaccines)
* Clinic Resources and Tools (including vaccine administration, clinical considerations and special populations, safety, storage and handling, staff training materials, and reimbursement)
* Patient Education Tools
* Vaccine Confidence and Hesitancy
* Frequently Asked Questions
* Key Contacts for COVID-19 Vaccine Information and Policies
There are three ways to easily locate the new web page:
* From the yellow box at the top of the IAC home page ([link removed])
* Use www.immunize.org/covid-19
* Go to the light blue band of tabs across the top of any IAC web page, choose the "Vaccines” tab, and then select “COVID-19”
The Vaccines: COVID-19 ([link removed]) web page will be updated frequently, so check back regularly for the most current information.
Related Links
* IAC’s Ask the Experts: COVID-19 ([link removed]) web page
* IAC’s Ask the Experts: COVID-19 and Routine Vaccination ([link removed]) web page
* IAC's Clinic Tools: Vaccination and COVID-19 ([link removed]) web page
------------------------------------------------------------
Reminder! Ask the Experts: COVID-19 web page answers your questions about COVID-19 vaccines
IAC recently created its Ask the Experts: COVID-19 ([link removed]) web page to answer questions about the administration of mRNA COVID-19 vaccines authorized for emergency use by the FDA and recommended by CDC’s Advisory Committee on Immunization Practices. This Ask the Experts web page also provides links to CDC guidance that will likely evolve. The Ask the Experts: COVID-19 ([link removed]) web page will grow as more information becomes available and whenever new vaccines are authorized.
IAC’s Ask the Experts ([link removed]) gateway page leads you to 29 distinct web pages on a variety of topics comprising a total of more than 1,000 common or challenging questions and answers (Q&As) about vaccines and their administration. IAC wishes to recognize its team of experts: Kelly L. Moore, MD, MPH (lead); Carolyn Bridges, MD, FACP; William Atkinson, MD, MPH; and Deborah Wexler, MD.
[link removed]
Related Links
* IAC’s Ask the Experts: COVID-19 ([link removed]) web page
* IAC’s Ask the Experts: COVID-19 and Routine Vaccination ([link removed]) web page
* IAC's Ask the Experts ([link removed]) gateway page to access more than 1,000 questions answered by IAC experts
------------------------------------------------------------
HHS announces $22 billion in funding to support expanded COVID-19 testing and vaccination
In a January 6 press release ([link removed]) , the Department of Health and Human Services (HHS) announced the Coronavirus Response and Relief Supplemental Appropriations Act will enable the CDC to provide more than $22 billion ([link removed]) [link removed] funding to states, localities, and territories to support the nation’s response to the COVID-19 pandemic.
The $22 billion includes $19 billion for testing and $3 billion for vaccination activities ([link removed]) . The funding is to be disbursed by January 19, 2021, to support testing and vaccination-related activities. Award recipients will include 64 jurisdictions including all 50 states, the District of Columbia, five major cities, and U.S. territories/islands. Funds will be allocated by a population-based formula.
For more information about CDC’s ongoing support to states, please visit this CDC's COVID-19 Budget Fact Sheet ([link removed]) gateway page.
Related Links
* HHS Press Release ([link removed]) (1/6/21)
* HHS's CDC Funding for COVID-19 Vaccination Activities ([link removed])
* HHS's CDC Funding for COVID-19 Testing ([link removed])
------------------------------------------------------------
HHS releases national strategic plan to address viral hepatitis in the U.S.
On January 7, the U.S. Department of Human Health Services (HHS) released its Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination 2021–2025 ([link removed]) to address this serious, preventable public health threat.
[link removed]
The Viral Hepatitis Plan for 2021–25 focuses on hepatitis A, hepatitis B, and hepatitis C, the three most common hepatitis viruses affecting the health of the nation. The plan identifies populations that experience the highest burden of viral hepatitis so that federal agencies and other stakeholders can focus their resources for the greatest effect.
The Viral Hepatitis Plan includes five goals to guide planning efforts:
* Prevent new viral hepatitis infections
* Improve health outcomes of people with viral hepatitis
* Reduce viral hepatitis-related disparities and health inequities
* Improve viral hepatitis surveillance and data use
* Achieve integrated, coordinated efforts that address the viral hepatitis epidemics among all partners and stakeholders
Related Links
* HHS's Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination 2021–2025 ([link removed])
* HHS's Viral Hepatitis National Strategic Plan Overview ([link removed]) webpage
* CDC's Viral Hepatitis ([link removed]) gateway page
------------------------------------------------------------
Voices for Vaccines releases new podcast, interviewing Stanley Plotkin on common COVID-19 vaccine questions
Voices for Vaccines (VFV) has posted a new entry in its Vax Talk podcast series: Let’s Ask Dr. Stanley Plotkin About These COVID-19 Vaccines ([link removed]) . A description from their web page is reprinted below.
Millions of people have received a COVID-19 vaccine, which gives us a lot of information about the safety of these vaccines. We asked Dr. Stanley Plotkin, inventor of the rubella vaccine and co-inventor of a rotavirus vaccine, to join us to answer our questions and to make some predictions.
[link removed]
Voices for Vaccines is a national organization of parents and others who are dedicated to raising the level of the voices of immunization supporters. VFV invites everyone who values vaccines to become a member, use VFV tools in their own community, and sign up for VFV’s free newsletter ([link removed]) . Please spread the word to your friends and colleagues to join VFV!
Related Links
* Voices for Vaccines ([link removed]) website
* Voices for Vaccines Tools ([link removed]) gateway page
* JoinVoices for Vaccines ([link removed]) and receive weekly email updates
* FollowVoices for Vaccines on Facebook ([link removed])
------------------------------------------------------------
“Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020” published in MMWR
CDC published Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020 ([link removed]) . A portion of the summary section is reprinted below.
ACIP recommends preexposure vaccination with Ervebo for adults aged ≥18 years in the U.S. population who are at highest risk for potential occupational exposure to Ebola virus species Zaire ebolavirus because they are responding to an outbreak of EVD, work as health care personnel at federally designated Ebola treatment centers in the United States, or work as laboratorians or other staff at biosafety level 4 facilities in the United States. Recommendations for use of Ervebo in additional populations at risk for exposure and other settings will be considered and discussed by ACIP in the future.
Access the MMWR article in HTML format ([link removed]) or in PDF format ([link removed]) .
Related Link
* MMWR ([link removed]) gateway page provides access to MMWR Weekly, MMWR Recommendations and Reports, MMWR Surveillance Summaries, and MMWR Supplements
------------------------------------------------------------
IAC experts called on by news media
With vaccines in the news so much lately, journalists have sought out IAC experts to communicate the intricacies of running a quality vaccination program. Our insights have helped explain vaccines to the public and policy makers. We want to help them understand the complex work vaccinators do. We've reached mass markets and local stations, across the U.S. and overseas, via print, radio, television, blogs, and more. Here is a selection of our recent citations:
* The Atlantic: The Next Phase of Vaccination Will Be Even Harder ([link removed] ) (1/7/21)
* Business Insider: Moderna's COVID-19 Vaccine May Cause Temporary Swelling for People with Facial Fillers ([link removed]) (12/30/20)
* Business Insider: In Rare Cases, COVID-19 Survivors Can Develop Psychosis and Suicidal Thoughts ([link removed]) (12/30/20)
* The Atlantic: Where Year Two of the Pandemic Will Take Us ([link removed]) (12/29/20)
* Minnesota Public Radio: Answering Questions about Vaccine Purgatory ([link removed]) (12/28/20)
* RadioLab: A Terrible COVID Christmas Special ([link removed]) (12/23/20)
------------------------------------------------------------
Not-to-miss immunization articles in the news
These recent articles convey the potential risks of vaccine-preventable diseases and the importance of vaccination.
* CNN:[link removed] Will Release Nearly All Available Vaccine Doses in Break from Trump Administration Policy of Holding Back Stock for Second Dose ([link removed]) (1/8/21)
* STAT: Scientists Are Monitoring a Coronavirus Mutation That Could Affect the Strength of Vaccines ([link removed]) (1/7/21)
* Medscape: How to Report COVID Vaccine-Related Adverse Events ([link removed]) (1/6/21)
* Live Science: COVID-19 Vaccines May Cause Allergic Reactions in 1 in 100,000 Jabs ([link removed]) (1/6/21)
* The Guardian: Misinformation 'Superspreaders': COVID Vaccine Falsehoods Still Thriving on Facebook and Instagram ([link removed]) (1/6/21)
* USA Today: COVID-19 Vaccine Doses Have Been Delivered but Are Sitting on Pharmacy Shelves. Longer Delays Could Prolong the Pandemic ([link removed]) (1/5/21)
* New York Times: Echoes of Another Pandemic: How The Times Covered the 1918 Flu ([link removed]) (1/5/21)
* New York Times: How Nine COVID-19 Vaccines Work ([link removed]) (1/5/21)
* Medical Express: State Laws Promoting Flu Vaccination for Hospital Workers May Help Prevent Deaths from Flu and Pneumonia ([link removed]) (1/5/21)
* NBC News: The COVID Vaccine Is Safe, Whatever Anti-vaxxers Say. Here's Why We Can Trust It ([link removed]) (1/4/21)
------------------------------------------------------------
Vaccine Information Statements
------------------------------------------------------------
IAC posts revised French translation of the MMRV Vaccine Information Statement (VIS)
IAC recently posted a revised French translation of the MMRV Vaccine (Measles, Mumps, Rubella, and Varicella) VIS ([link removed]) . The translation was generously contributed by Georgetown Translators.
[link removed]
Related Links
* English-language version of the ([link removed]) MMRV Vaccine (Measles, Mumps, Rubella, and Varicella) VIS ([link removed])
* French-language translation ([link removed]) MMRV Vaccine (Measles, Mumps, Rubella, and Varicella) VIS ([link removed])
* IAC's French-language versions of VISs ([link removed])
* IAC's MMRV Vaccine (Measles, Mumps, Rubella, and Varicella) VIS ([link removed]) gateway page
* IAC's VIS gateway page grouped by vaccine ([link removed])
* IAC’s VISs grouped in up to 49 languages ([link removed])
* CDC's What's New with VISs ([link removed]) gateway page
* CDC's VIS gateway page ([link removed])
------------------------------------------------------------
IAC Handouts
------------------------------------------------------------
NEW! IAC PUBLISHES “COVID-19 MRNA VACCINES: WHAT CLINIC PERSONNEL NEED TO KNOW,” A SIDE-BY-SIDE COMPARISON OF PFIZER-BIONTECH AND MODERNA COVID-19 VACCINES
IAC has released its newest resource for healthcare professionals, COVID-19 mRNA Vaccines: What Clinic Personnel Need to Know ([link removed]) , a 5-page summary offering a side-by-side comparison of the two FDA-authorized mRNA COVID-19 vaccines.
The table lists key characteristics of and resources for the Pfizer-BioNTech and Moderna mRNA vaccines. The resource presents information on each vaccine, including summary guidance and links to key resources available from CDC, FDA, and the vaccine manufacturers. Topics covered for each vaccine include:
* Age indication
* Presentation and packaging
* Storage and handling
* Vaccine preparation and administration
* Vaccine safety
* Vaccine product and administration codes
[link removed]
“COVID-19 mRNA Vaccines: What Clinic Personnel Need to Know” will be updated as new key resources become available.
Related Links
* IAC’s Handouts: COVID-19 ([link removed]) web page
* IAC’s Handouts for Patients and Staff ([link removed]) gateway page, where you can sort materials by topic, vaccine, or language
* IAC’s Educational Materials for Patients and Staff ([link removed]) —an alphabetical listing of more than 300 ready-to-print staff educational materials and patient handouts
* IAC's Vaccines: COVID-19 ([link removed]) web page
* IAC’s Ask the Experts: COVID-19 ([link removed]) web page
------------------------------------------------------------
IAC updates “Decision to Not Vaccinate My Child – Declination Form”
IAC recently revised its Decision to Not Vaccinate My Child – Declination Form ([link removed]) , adding “Declination Form” to the title and updating explanatory statements and references.
[link removed]
Related Links
* IAC's Handouts: Documenting Vaccination ([link removed]) gateway page
* IAC’s Handouts for Patients and Staff ([link removed]) gateway page, where you can sort materials by topic, vaccine, or language
* IAC’s Educational Materials for Patients and Staff ([link removed]) —an alphabetical listing of more than 300 ready-to-print staff educational materials and patient handouts
------------------------------------------------------------
Featured Resources
------------------------------------------------------------
CHOP’s Vaccine Education Center releases English- and Spanish-language versions of their COVID-19 mRNA Q&As
Children's Hospital of Philadelphia's (CHOP) Vaccine Education Center has released a 4-page, printable Q&A for the public titled COVID-19 mRNA Vaccines: What You Should Know ([link removed]) .
View the handout in Spanish ([link removed]) .
[link removed]
As with their other Q&A sheets, these sheets can be photocopied for distribution, and the links can be added to websites. Print versions will be available in coming weeks.
Related Links
* CHOP's Questions and Answers about COVID-19 Vaccines ([link removed]) web page
* The Vaccine Makers Project's The Coronavirus Pandemic––Answering Your Questions ([link removed]) web page
------------------------------------------------------------
IN IAC’S “VIDEO OF THE WEEK,” CDC'S DR. AMANDA COHN EXPLAINS HOW ACIP ADVISES CDC ON USE OF VACCINES
In this CDC video ([link removed]) , Dr. Amanda Cohn, executive secretary of CDC’s Advisory Committee on Immunization Practices (ACIP), explains that ACIP consists of independent experts who debate and develop recommendations on using vaccines to control vaccine-preventable diseases, including COVID-19. The committee prioritizes safety and effectiveness while reviewing scientific evidence.
[link removed]
Visit the whole collection at the VOTW archive ([link removed]) .
------------------------------------------------------------
USE IAC’S EXPANDED “REPOSITORY OF RESOURCES FOR MAINTAINING IMMUNIZATION DURING THE COVID-19 PANDEMIC” TO CATCH UP PEOPLE WHO FELL BEHIND
IAC now offers more than 275 items in its Repository of Resources for Maintaining Immunization during the COVID-19 Pandemic ([link removed]) gateway page to assist in maintaining routine immunization rates during the COVID-19 pandemic. Located on the website of the National Network of Immunization Coalitions ([link removed]) , a project of IAC, this repository includes links to both national and state-level policies and guidance; advocacy materials, including talking points, webinars, press releases, articles, and social media posts; and telehealth resources.
These resources are intended for healthcare settings, state and local health departments, professional societies, immunization coalitions, advocacy groups, and the community to use in their efforts to sustain routine immunizations during the COVID-19 pandemic. The resources can be sorted and searched by date, title, geographic area, source, type, age category, or setting.
[link removed]
If you have a resource to suggest for the repository, please send a message to [email protected] (mailto:[email protected]) .
Related Link
* National Network of Immunization Coalitions ([link removed]) website
------------------------------------------------------------
Newly updated 65+ Flu Defense website offers resources for healthcare professionals serving older adults
Confident recommendations for flu vaccine from healthcare providers are powerfully persuasive and make a significant difference in decisions your patients make about vaccination. To assist you in maximizing protection for your patients, IAC, in collaboration with Seqirus, has updated the 65+ Flu Defense website at www.influenza-defense.org ([link removed]) .
A new fact sheet on the site, ([link removed]) The Importance of Preventing Influenza during a Pandemic ([link removed]) , ([link removed]) [link removed] responses to help guide discussions with patients on the increased importance of flu vaccination during the COVID-19 pandemic. Age increases risks associated with COVID-19 infection including hospitalization and death. Preliminary studies suggest coinfection with influenza B and SARS-CoV-2 may elevate the risk of poor outcomes.
[link removed]
This helpful site includes information, tools, and tips for communicating with these adults about the scope and severity of influenza, for example:
* Influenza in Adults 65+: The Facts ([link removed])
* Influenza Vaccination: Questions Patients Age 65 and Older Frequently Ask Their HCP ([link removed])
Be sure to check out the updated 65+ Flu Defense website at www.influenza-defense.org ([link removed]) to assist your efforts in protecting this vulnerable population.
------------------------------------------------------------
=GREAT FOR WORKPLACE RECOGNITIONS! IAC’S ELEGANTLY DESIGNED “VACCINES SAVE LIVES” BLACK ENAMEL PINS SHOW HOW MUCH YOU VALUE VACCINATION.=
IAC’s elegantly designed “Vaccines Save Lives” pins ([link removed]) are meaningful gifts for people who care about immunization. The pin makes a refined statement in hard black enamel with gold lettering and edges, measuring 1.125" x 0.75".
[link removed]
The pin is a stick-through-post variety with the back end covered by a round rubber cap that holds the pin securely. A gold metal spring-lock clasp is also provided.
Wear these pins on clothing, ([link removed]) uniforms, and white coats to show that you value vaccines! They make a meaningful gift for people who care about immunization.
([link removed])
Click here for "Vaccines Save Lives" pin pricing and ordering information. ([link removed])
------------------------------------------------------------
CHECK OUT IAC’S NEW WEBSITE MASS-VACCINATION-RESOURCES.ORG TO FIND RESOURCES TO HELP SET UP YOUR MASS VACCINATION CLINICS—NEW RESOURCES ADDED!
The Immunization Action Coalition’s newest website, www.Mass-Vaccination-Resources.org ([link removed]), assists you in finding a wide range of ideas for developing your own mass vaccination clinics. Mass vaccination efforts will be useful for expediting flu vaccination this fall and may be needed after COVID-19 vaccines are licensed for use in large groups of people.
The website features a searchable list of resources for a variety of venues, including curbside, drive-through, and walk-through clinics; mobile medical vans; pharmacies; and schools. The database contains guidance documents, toolkits, publications, and other helpful resources that can be adapted to your community or individual healthcare setting.
Many of the documents were written in the pre-pandemic era and will need modification to ensure that additional protections, such as social distancing and personal protective equipment, help safeguard against COVID-19 transmission.
[link removed]
More resources have been added including:
* COVID-19 Vaccination Program Provider Requirements and Support ([link removed])
* COVID-19 Vaccination Resources for Providers ([link removed])
* Enrollment Process to Bill CMS for Vaccination Services ([link removed])
* COVID-19 Mass Vaccination Planning Guide ([link removed])
In addition, IAC's archived, full-length webinar highlighting best practices and offering practical information for conducting a successful mass vaccination clinic, Mass Vaccination Clinics: Challenges and Best Practices ([link removed]) , can also be viewed on www.Mass-Vaccination-Resources.org ([link removed]) .
If you have a resource to suggest for the website, please send a message to [email protected] (mailto:[email protected]) .
The webinar and the new website are supported by a medical education grant from Seqirus.
Related Links
* IAC's Mass Vaccination Resources ([link removed]) website
* CDC’s Guidance for Planning Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations ([link removed])
* IAC's Mass Vaccination Clinics: Challenges and Best Practices ([link removed]) archived webinar
* Becker’s Hospital Review: Influenza Vaccination Is More Important than Ever: To Help, Immunization Action Coalition Launches New Mass Vaccination Resources ([link removed])
------------------------------------------------------------
Journal Articles and Newsletters
------------------------------------------------------------
“A Quality Improvement Learning Collaborative for Human Papillomavirus Vaccination” published in Pediatric Quality and Safety
In the January/February 2021 issue, Pediatric Quality and Safety published A Quality Improvement Learning Collaborative for Human Papillomavirus Vaccination ([link removed]) . The senior author on the project is IAC’s Sharon G. Humiston, MD, MPH. The conclusion section is reprinted below.
This learning collaborative aimed to engage multiple AAP chapters and pediatric practices to teach QI skills and improve HPV vaccination rates using the Project ECHO telementoring platform. At the chapter level, the collaborative demonstrated success in satisfaction and in teaching the necessary skills to allow all participating chapters to go on to lead HPV QI learning collaboratives of their own. At the practice level, participants gained confidence in HPV vaccine communication and QI skills. The collaborative demonstrated early improvements in reducing missed opportunities to vaccinate, while the impact on HPV vaccination initiation and completion lagged. Future projects should be extended for more than 8 data cycles or use more frequent data collection to capture this change and further identify barriers to system-level change.
------------------------------------------------------------
“Population Mortality and Laws Encouraging Vaccination for Hospital Workers” published in Annals of Internal Medicine
In the January 5 issue, Annals of Internal Medicine published Population Mortality and Laws Encouraging Vaccination for Hospital Workers ([link removed]) . The conclusion section is reprinted below.
State laws promoting hospital worker vaccination against influenza may be effective in preventing pneumonia- and influenza-related deaths, particularly among elderly persons. Vaccinating hospital workers may substantially reduce the spread of influenza and protect the most vulnerable populations.
------------------------------------------------------------
Education and Training
------------------------------------------------------------
MODERNA SCIENTISTS WILL OFFER TWO WEBINARS REGARDING MRNA COVID-19 VACCINATION ON JANUARY 14 AND 19
Moderna will offer two webinars on mRNA vaccination against SARS-CoV-2, the virus that causes COVID-19. Ashfield Healthcare will coordinate the webinars on behalf of Moderna. CE credit will not be offered for these webinars.
On January 14, the webinar titled Important Information for Healthcare Providers about Moderna COVID-19 Vaccine ([link removed]) will start at 11:00 a.m. (ET).
Register for the January 14 webinar. ([link removed])
On January 19, the webinar Examining the SARS-CoV-2 Pandemic and the Moderna COVID-19 Vaccine: A Panel Discussion will be held from 7:00–8:00 p.m. (ET). This will be a conversational 1-hour presentation examining evolving epidemiology, the vaccine development timeline, the mRNA mechanism of action, and clinical data supporting an Emergency use Authorization (EUA).
Register for the January 19 webinar. ([link removed])
Related Links
* FDA's Moderna COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers ([link removed])
* FDA's Moderna COVID-19 Vaccine EUA Fact Sheet for Recipients and Caregivers ([link removed])
------------------------------------------------------------
On the Lighter Side
------------------------------------------------------------
IN THIS CUTE 1998 PSA FROM NEVADA HEALTH DIVISION, A BABY’S TOYS INFORM HER THAT SHE CAN GET THE CHICKENPOX VACCINE
In this cute 1998 public service announcement (PSA) ([link removed]) from the Nevada Health Division, a baby’s toys explain the importance of getting the chickenpox vaccine to help protect her from the potentially deadly disease. This PSA is part of a collection curated by vaccine expert William L. Atkinson, MD, MPH.
[link removed]
Previous PSAs featured in “On the Lighter Side” are available when viewing this Vimeo video ([link removed]).
[link removed]
IAC Express
IAC Express Home ([link removed])
2020 Issues ([link removed])
2019 Issues ([link removed])
2018 Issues ([link removed])
2017 ([link removed]) – (#IACX4) 1997 Issues ([link removed])
[link removed]
[link removed]
------------------------------------------------------------
Video of the Week
[link removed]
How CDC Develops COVID-19 Vaccine Recommendations: Dr. Amanda Cohn, executive secretary of CDC’s Advisory Committee on Immunization Practices (ACIP), explains that ACIP consists of independent experts who debate and develop recommendations on using vaccines to control vaccine-preventable diseases, including COVID-19. The committee prioritizes safety and effectiveness while reviewing scientific evidence. [1:44]
Visit the VOTW archive ([link removed])
------------------------------------------------------------
[link removed]
[link removed]
------------------------------------------------------------
Follow Us
[link removed]
[link removed]
------------------------------------------------------------
Technically Speaking
[link removed]
Read Dr. Wexler's column for the Vaccine Education Center's monthly newsletter, Vaccine Update
------------------------------------------------------------
[link removed]
[link removed]
------------------------------------------------------------
Vaccinating Adults:
A Step-by-Step Guide
[link removed]
New! IAC's 142-page book available for free download ([link removed]) .
------------------------------------------------------------
Calendar of Events
[link removed]
Conferences, meetings, and training opportunities
------------------------------------------------------------
Patient Record Cards
[link removed]
Record cards for patients --child & teen ([link removed]) , adult ([link removed]) , and lifetime ([link removed]) -- are printed on durable paper and sized to fit in a wallet when folded
------------------------------------------------------------
DVD: Immunization Techniques
[link removed]
Every practice should have this award winning, "how-to" training video
------------------------------------------------------------
Protect Newborns Guidebook
[link removed]
Comprehensive guide Hepatitis B: What Hospitals Need to Do to Protect Newborns ([link removed])
------------------------------------------------------------
Editorial Information
Editor
Deborah L. Wexler, MD (mailto:[email protected])
Associate Editors
John Grabenstein, RPh, PhD (mailto:[email protected])
Sharon Humiston, MD, MPH (mailto:[email protected])
Consulting Editors
Taryn Chapman, MS (mailto:[email protected])
Marian Deegan, JD (mailto:[email protected])
Courtnay Londo, MA (mailto:[email protected])
Technical Editor
Liv Augusta Anderson, MPP (mailto:[email protected])
About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue. ([link removed] )
IAC Express is supported in part by Grant No. 6NH23IP922550 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC.
IAC Express Disclaimer ([link removed])
ISSN: 1526-1786
Our mailing address:
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp